This Action aims at using innovative translational research to identify colorectal cancer biomarkers for personalized medicine that will improve screening, early detection and disease follow-up, and attain better tumor profiling, state-of-the-art functional characterization of genetic variants and new therapy approaches

Read more

  • Cooperation studies on inherited susceptibility to colorectal cancer
  • TRANSCOLONCAN Group
  • Graphic

News

InSIGHT conference on gastrointestinal hereditary tumors

Thursday, 18 April 2019

Last month, TRANSCOLONCAN participant Mev Dominguez-Valentin from Oslo University Hospital gave a lecture at the International Society for Gastrointestinal Hereditary Tumors (InSIGHT) Conference held in Auckland, New Zealand.

More about "InSIGHT conference on gastrointestinal hereditary tumors"


COST is supported by the EU Framework Programme Horizon 2020